Increased superoxide anion production by interleukin-1β impairs nitric oxide-mediated relaxation in resistance arteries

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 1, 2006, Pages 42-52

  Jiménez Altayó, Francesc ^a   Briones, Ana M ^a,c   Giraldo, Jesús ^a   Planas, Anna M ^b   Salaices, Mercedes ^c   Vila, Elisabet ^a,d  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d INSTITUT DE NEUROCIÈNCIES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDINE DERIVATIVE; ACETYLCHOLINE; ALLOPURINOL; APOCYNIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MACROGOL; N 3 AMINOMETHYLBENZYLACETAMIDINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITE; NITROPRUSSIDE SODIUM; OXIDOREDUCTASE INHIBITOR; PROTEIN P22; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTERY RESISTANCE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; FLUORESCENCE; IMMUNOFLUORESCENCE; MALE; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASODILATATION; WESTERN BLOTTING;

EID: 29244448978     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.088435     Document Type: Article

References (40)

1. Brandes RP, Koddenberg G, Gwinner W, Kim D, Kruse HJ, Busse R, and Mugge A (1999) Role of increased production of superoxide anions by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia. Hypertension 33:1243-1249.
2. Brandes RP and Kreuzer J (2005) Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 65:16-27.
3. Briones AM, Salaices M, and Vila E (2005) Ageing alters the production of nitric oxide and prostanoids after IL-1β exposure in mesenteric resistance arteries. Mech Ageing Dev 126:710-721.
4. Buga GM, Griscavage JM, Rogers NE, and Ignarro LJ (1993) Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 73:808-812.
5. Cai H, Griendling KK, and Harrison DG (2003) The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24:471-478.
6. Cai H and Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840-844.
7. Das UC (2000) Critical advances in septicemia and septic shock. Crit Care 4:290-296.
8. De Frutos T, de Miguel LS, Garcia-Duran M, Gonzalez-Fernandez F, Rodriguez-Feo JA, Monton M, Guerra J, Farre J, Casado S, and Lopez-Farre A (1999) NO from smooth muscle cells decreases NOS expression in endothelial cells: role of TNF-alpha. Am J Physiol 277:H1317-H1325.
9. De Salvatore G, De Salvia MA, Piepoli AL, Natale L, Porro C, Nacci C, Mitolo CI, and Mitolo-Chieppa D (2003) Effects of in vivo treatment with interleukins 1beta and 6 on rat mesenteric vascular bed reactivity. Auton Autacoid Pharmacol 23:125-131.
10. Dresler H and Horning B (1999) Endothelial dysfunction in human disease. J Mol Cell Cardiol 31:51-60.
11. 15N]nitrate in biological fluids. Anal Biochem 126:131-138.
12. Griendling KK, Sorescu D, and Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494-501.
13. Gunnett CA, Heistad DD, Berg DJ, and Faraci FM (2000) IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am J Physiol 279:H1555-H1562.
14. Guzik TJ, Korbut R, and Adamek-Guzik T (2003) Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54:469-487.
15. Hamilton CA, Brosnan MJ, Al-Benna S, Berg G, and Dominiczak AF (2002) NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 40:755-762.
16. Hernanz R, Alonso MJ, Briones AM, Vila E, Simonsen U, and Salaices M (2003) Mechanisms involved in the early increase of serotonin contraction evoked by endotoxin in rat middle cerebral arteries. Br J Pharmacol 140:671-680.
17. Hernanz R, Briones AM, Alonso MJ, Vila E, and Salaices M (2004) Hypertension alters role of iNOS, COX-2 and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteries. Am J Physiol 287:H225-H234.
18. Kaur J, Dhaunsi GS, and Turner RB (2004) Interleukin-1 and nitric oxide increase NADPH oxidase activity in human coronary artery smooth muscle cells. Med Princ Pract 13:26-29.
19. Kessler P, Bauersachs J, Busse R, and Schini-Kerth VB (1997) Inhibition of inducible nitric oxide synthase restores endothelium-dependent relaxations in proinflammatory mediator-induced blood vessels. Arterioscler Thromb Vasc Biol 17:1746-1755.
20. Loughrey JP, Laffey JG, Moore BJ, Lynch F, Boylan JF, and McLoughlin P (2003) Interleukin-1 beta rapidly inhibits aortic endothelium-dependent relaxation by a DNA transcription-dependent mechanism. Crit Care Med 31:910-915.
21. Lu LF and Fiscus RR (1999) Interleukin-1beta causes different levels of nitric oxide-mediated depression of contractility in different positions of rat thoracic aorta. Life Sci 64:1373-1381.
22. McKenna TM, Clegg JM, and Williams TJ (1994) Protein kinase C is a mediator of lipopolysaccharide-induced vascular suppression in the rat aorta. Shock 2:84-89.
23. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, and Davidson BL (1998) Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82:1298-1305.
24. Milstien S and Katusic Z (1999) Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 263:681-684.
25. Nakamura M, Yoshida H, Arakawa N, Saitoh S, Satoh M, and Hiramori K (2000) Effects of tumor necrosis factor-alpha on basal and stimulated endothelium-dependent vasomotion in human resistance vessel. J Cardiovasc Pharmacol 4:487-492.
26. Newman WH, Zhang LM, Leeper-Woodford SK, and Castresana MR (1996) Human blood vessels release tumor necrosis factor-α from a smooth muscle source. Crit Care Med 24:294-297.
27. Papapetropoulos A, Abou-Mohamed G, Marczin N, Murad F, Caldwell RW, and Catravas JD (1996) Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta. Br J Pharmacol 118:1359-1366.
28. Piepot HA, Boer C, Groeneveld ABJ, Lambalgen AA, and Sipkema P (2000) Lipopolysaccharide impairs endothelial nitric oxide synthesis in rat renal arteries. Kidney Int 57:2502-2510.
29. Riedemann NC, Guo R-F, and Ward PA (2003) Novel strategies for the treatment of sepsis. Nat Med 9:517-524.
30. Salvemini D, Ischiropoulos H, and Cuzzocrea S (2003) Roles of nitric oxide and superoxide in inflammation. Methods Mol Biol 225:291-303.
31. Touyz RM and Schiffrin EL (2004) Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 22:339-352.
32. Tsuchida S, Hiraoka M, Sudo M, Kigoshi S, and Muramatsu I (1994) Attenuation of sodium nitroprusside responses after prolonged incubation of rat aorta with endotoxin. Am J Physiol 267:H2305-H2310.
33. Ungvari Z, Csiszar A, Edwards JG, Kaminski PM, Wolin MS, Kaley G, and Koller A (2003) Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 23:418-424.
34. Vila E and Salaices M (2005) Cytokines and vascular reactivity in resistance arteries. Am J Physiol 288:H1016-H1021.
35. Virdis A, Colucci R, Fornai M, Blandizzi C, Duranti E, Pinto S, Bernardini N, Segnani C, Antonioli L, Taddei S, et al. (2005) Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress. J Pharmacol Exp Ther 312:945-953.
36. Visner GA, Chesrown SE, Monnier J, Ryan US, and Nick HS (1992) Regulation of manganese superoxide dismutase: IL-1 and TNF induction in pulmonary artery and microvascular endothelial cells. Biochem Biophys Res Commun 188:453-462.
37. Wimalasundera R, Fexby S, Regan L, Thom SA, and Hughes AD (2003) Effect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. Br J Pharmacol 138:1285-1294.
38. Wylam ME, Metkus AP, and Umans JG (2001) Nitric oxide dependent and independent effects of in vitro incubation or endotoxin on vascular reactivity in rat aorta. Life Sci 69:455-467.
39. Yoshizumi M, Perrella MA, Burnett JC Jr, and Yoshizumi Lee ME (1993) Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73:205-209.
40. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, and Diez J (2001) Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 38:1395-1399.